FILTER
FILTERED INTERVIEW RESULTS
Francesco Trisolini
CEO, HOSPITEX
Hospitex explains how its cytological diagnostics services are expanding globally.
Fabio Fiscaletti
CEO, MASTELLI
Mastelli is a small Italian pharma company with bold plans for expansion.
Michele Diaferia
CEO, ITEL GROUP
Itel Group describes the on-going development of its proton linear accelerator.
Nanding Zhao
CEO, NERVIANO MEDICAL SCIENCES (NMS) GROUP
NMS is one of the largest kinase inhibitors-focused oncology drug discovery companies in Italy.
Giovanni Mariani
CEO, LISAPHARMA
Lisapharma describes the challenges Italian pharma producers have experienced over the past two years.
Rocco Pavese
CEO, GENETIC SPA
Genetic is an Italian CDMO founded in 2007 dedicated to the research and development, manufacturing, licensing-out and marketing of medicines.
Alessia Valducci
CEO, VALPHARMA
Valpharma is an Italian CMO involved in pharmaceutical development and contract manufacturing specializing in solid oral dosage medicines and nutraceuticals, both developed with modified-release technologies.
Pasquale de Blasio
FOUNDER, INTEGRATED SYSTEMS ENGINEERING (ISE)
Integrated Systems Engineering sets out its objectives to develop its TMA technology and move it into diagnostics and to build a biobank of organoids.
Giorgio Palu
PRESIDENT, AIFA
The Italian Medical Agency (AIFA) explains the current issues facing Italy’s life science industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
